|
|
||||||||
Ann Thorac Surg 2003;76:523-527
© 2003 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Hebrew University, Hadassah Medical School, Jerusalem, Israel
Accepted for publication February 14, 2003.
* Address reprint requests to Dr Gerrah, Department of Cardiothoracic Surgery, Hadassah University Hospital, P.O. 12000, Jerusalem 91120, Israel
e-mail: rgerrah{at}yahoo.com
| Abstract |
|---|
|
|
|---|
METHODS: Forty-two patients with glucose-6-phosphate dehydrogenase deficiency underwent open heart procedures using cardiopulmonary bypass. This group was matched with a control group of identical size for comparison of operative course and postoperative outcome. The perioperative variables were compared between the two groups using univariate and multivariate analysis.
RESULTS: The duration of ventilation after the operation was significantly longer in the glucose-6-phosphate dehydrogenasedeficient group (13.7 ± 7.6 hours versus 7.7 ± 2.8 hours; p < 0.0001). Minimal value of arterial oxygen tension was lower in patients with glucose-6-phosphate dehydrogenase deficiency (66 ± 12 mm Hg versus 85 ± 14 mm Hg; p < 0.0001), and more cases of hypoxia (arterial oxygen tension < 60 mm Hg) were found in this group (11 versus 1; p = 0.001). Compared with the control group, patients with glucose-6-phosphate dehydrogenase deficiency had significantly elevated hemolytic indices expressed by bilirubin levels (26 ± 10 mmol/L versus 17 ± 6.7 mmol/L; p < 0.0001) and lactic dehydrogenase levels (970 ± 496 U/L versus 505 ± 195 U/L; p < 0.0001). They also required significantly more blood transfusion perioperatively (1.9 ± 1.4 packed cell units/patient versus 0.8 ± 1.0 packed cell units/patient; p = 0.0001).
CONCLUSIONS: Patients with glucose-6-phosphate dehydrogenase deficiency who are undergoing cardiac surgery may have a more complicated course with a longer ventilation time, more hypoxia, increased hemolysis, and a need for more blood transfusion. Because this difference may be caused by subnormal free radical deactivation, strategies that minimize bypass in general and free radicals specifically may be beneficial.
| Introduction |
|---|
|
|
|---|
The main end product of the hexose monophosphate pathway is reduced nicotinamide dinucleotide diphosphate, a key metabolite that plays a major role in minimizing the devastating effects of oxidative injury to cells (mainly red blood cells) by free radicals [3]. An important metabolite that inhibits oxidative injury is glutathione in its sulfhydryl reduced form (G-SH). A prototype reaction between reduced glutathione and a free radical (H2O2) is 2 G-SH + H2O2
G-S-S-G + 2H2O.
Reduced nicotinamide dinucleotide diphosphate, the end product of the hexose monophosphate pathway mediated by G6PD, reduces the oxidized glutathione to its effective form. Shifting the balance between the protective antioxidant mechanisms and the production of free radicals, with consequent accumulation of radicals, will damage membranes, resulting in hemolysis of red blood cells.
Cardiac surgery in its conventional form involves many processes in which cell damage is likely to occur. Perioperative ischemia and reperfusion, circulation of whole body blood through the cardiopulmonary bypass (CPB) circuit, hypothermia, acidosis, and hypoperfuassion and hyperperfusion are all events that commonly occur during cardiac operations [4, 5]. These events lead to increased production of free radicals, resulting in damage to almost every organ [68]. Preoperative administration of free radical scavengers reduced postoperative hemolysis and inflammatory response after open heart procedures [911]. Lung injury as a result of free radicals is known to occur in mechanically ventilated patients. Depletion of leukocytes, a major source of free radicals, has ameliorated free radicalmediated lung injury after CPB [12]. In most cases, however, protective mechanisms are initiated, and they neutralize most of the potentially damaging substances. Whether deficiency in G6PD potentiates the harmful effect of free radicals in such patients undergoing cardiac surgery has never been investigated.
In the present study we examined whether G6PD-deficient patients undergoing a cardiac operation showed evidence of greater hemolysis and need for blood transfusions and whether G6PD deficiency increased the perioperative and postoperative pulmonary-related morbidity.
| Material and methods |
|---|
|
|
|---|
The selection of patients in the control group was based on a 1:1 case-control study. For each case in the study group, a control patient was randomly matched using our computerized database as follows: same age, same sex, same type of operation, and presence of chronic obstructive pulmonary disease, diabetes mellitus, hypertension, and duration of CPB (Table 1).
|
Postoperative fluid and transfusion management was according to standard protocols, identical for all patients in the study and the control groups. Blood was transfused for hemodynamic instability in patients with significant chest drainage or when the hemoglobin value was less than 8 g/dL, or less than 10 g/dL concomitant with symptoms related to anemia. Plasma was transfused to correct coagulation disorders in bleeding patients.
The postoperative complications and outcome, including ICU stay and total hospitalization time, were also recorded.
Statistical analysis
Data were analyzed both at the univariate and multivariate levels. The univariate analyses included the Students t test for comparison of the two groups for quantitative variables, the
2 test for the assessment of association between two categorical variables, and the Pearson correlation coefficient for the calculation of correlation between two quantitative variables. The multivariate analysis that was applied was analysis of covariance (ANCOVA). This model was used for almost all of the clinical outcome variables, which were regarded as dependent variables in this study, when quantitative. Analysis of covariance was applied twice on each of the dependent variables. Stage one included all of the potential explanatory variables (defined in the Results), and the second time included only the independent variables that were found to be statistically significant (p
0.05) at the first stage of the ANCOVA analysis. Data are presented as mean ± standard deviation. The p value of less than 0.05 is considered statistically significant.
| Results |
|---|
|
|
|---|
|
Of the 31 patients who underwent coronary artery bypass grafting in each group, one internal thoracic artery was used for bypass in 29 patients of the study group and in 30 of the control group. The mean number of grafts in coronary artery bypass grafting operations was similar in the study and the control group. An insignificant difference was also found between the G6PD-deficient group and the control group in the duration of aortic cross-clamping (58 ± 29 minutes versus 60 ± 17 minutes, respectively). The volume of cardioplegic solution and the lowest core temperature did not differ significantly between the groups. Operation time was longer in the study group (4.3 ± 0.7 hours versus 3.8 ± 0.4 hours in control group, p = 0.004). The postoperative data are summarized in Table 3. Each one of the clinical outcomes that was found to be significantly different between the study and the control groups was regarded as a dependent variable, and the ANCOVA model was applied to it. The following variables were always initially entered into the model as independent variables (some were considered to be confounders and others to be risk factors): disease state (G6PD deficiency or normal subject), chronic obstructive pulmonary disease, urgency of operation, platelet count, operation time, CPB time, aortic cross-clamp time, degree of hypothermia, chest drainage, amount of crystalloid fluid administration and urine output during the first 24 postoperative hours, and the difference between them (fluid balance).
|
Postoperative hemolysis and transfusion requirements
The lowest hemoglobin value, recorded immediately after the operation, was 9.1 ± 0.9 g/dL in the study group, compared with 10.4 ± 1.1 in the control group (p < 0.0001). Of the 42 patients in each group, 31 in the G6PD-deficient group (73%) and 16 in the control group (38%) received blood transfusions (p = 0.001). The G6PD-deficient patients required a significantly larger number of blood transfusions (1.9 ± 1.4 U/patient) than did the control group patients (0.8 ± 1.0 U/patient; p = 0.0001). The hemoglobin values on discharge were still lower in the study group (10.9 ± 1.0 g/dL) than in the control group (12.1 ± 1.0 mg/dL; p = 0.0001). A significant correlation was found between operative temperature and hemoglobin at discharge in the study group (r = 0.6; p < 0.05), but not in the control group (r = 0.1).
Both groups had significantly higher levels of total bilirubin and lactate dehydrogenase on the first day after the operation compared with preoperative values. Postoperative bilirubin was 26 ± 10 µmol/L in the study group and 17 ± 6.7 µmol/L in the control group (p < 0.0001). Postoperative lactate dehydrogenase levels were 970 ± 496 U/L in the study group versus 505 ± 195 U/L in the control group (p < 0.0001).
Mean urine output during the first 24 hours after operation was 1,840 ± 550 mL in the G6PD-deficient group, and this was significantly lower than that in the control group (2,400 ± 890 mL; p = 0.001). In the study group there was a mild but significant increase (p < 0.05) in the creatinine level measured 24 hours after surgery (Table 3). The volume of mediastinal drainage was 590 ± 260 mL (study) versus 490 ± 280 mL (control), but the difference did not reach statistical significance (p = 0.09).
When the ANCOVA model was applied it was found that hemoglobin values (minimal, at discharge from the ICU, and on discharge from the hospital) were unrelated to chest drainage or to hemodilution (positive fluid balance) and were predicted strongly by the group (p < 0.0001, p < 0.0001, and p = 0.04, respectively). The need for blood transfusion was also highly dependent on the group (p = 0.001).
Intensive care unit and hospital stay
The patients with G6PD deficiency had a similar ICU stay to the control group: 2.7 ± 1.3 days versus 2.3 ± 1.4 days (p = 0.1), and no difference was found in the duration of hospital stay (p = 0.2). According to the ANCOVA model, hospital stay in both groups was dependent on the degree of hypothermia (p = 0.01) and on CPB time (p = 0.01). Interestingly, CPB time correlated very well with the duration of hospital stay in the G6PD-deficient group (r = 0.6, p < 0.05), although the correlation between the same variables was not significant in the control group (r = 0.2).
Postoperative complications, which prolonged hospitalization in the study group, included atrial fibrillation in 6 patients, chest wound infection in 3 patients (requiring surgical reconstruction in one of them), stroke with hemiparesis (n = 1), renal failure (n = 1), low cardiac output (n = 1), complete atrioventricular block (n = 1), and pneumonia (n = 1). In the control group 10 patients had postoperative complications: atrial fibrillation (n = 5), superficial wound infection (n = 2), adult respiratory distress syndrome (n = 1), low cardiac output necessitating intraaortic balloon counterpulsation (n = 1), and urinary tract infection (n = 1).
Thirty-seven of the 42 patients (88%) in the group with G6PD deficiency and 40 of the 42 patients (95%) in the control group were discharged to their homes. Four of the 42 (9.5%) in the study group and 2 of 42 (4.7%) in the control group were transferred to another ward for treatment of postoperative complications or because of the need for rehabilitation after a neurologic event.
| Comment |
|---|
|
|
|---|
Operation time was longer in the study group. Transfusion of blood after conclusion of the operation but before transfer to the ICU, with observation for immediate reactions, and stabilization of blood gases before transport may have been responsible for the prolongation of operative time in this group. Intensive care unit and total hospital stays were equal for both groups. Yet, although the knowledge that patients had enzyme deficiency might have influenced the postoperative care of these patients, they were more prone to complications secondary to hypoxemia and longer ventilation time on the one hand, and excessive hemolysis and need for more blood on the other hand. Hence, one could consider the deficiency of G6PD to be a risk factor in cardiac surgery incorporating cardiopulmonary bypass.
In recent years an increasing number of coronary artery bypass grafting operations are performed without CPB and with good results. Taking into account that CPB is more deleterious to G6PD-deficient patients, off-pump bypass operations could not only reduce oxidative stress and inflammation [14], but could also reduce the risk of blood loss caused by hemolysis and the need for foreign blood transfusion. Further study is necessary to show whether this approach will be of greater benefit for patients with G6PD deficiency.
In conclusion, patients deficient in G6PD demonstrated impaired oxygenation, prolonged ventilation, increased hemolysis, and increased need for blood transfusion after open heart procedures compared with control patients. On reperfusion after a period of ischemia, the antioxidant system recruits all of its components in an attempt to neutralize the overwhelming oxidative stress of free radicals. A defect in any one of the components of the antioxidant system will shift the balance toward excessive oxidative damage. Minimizing reperfusion injury is an important goal after surgery as it may improve outcome. Every effort should be made to reduce the formation of free radicals and to increase their deactivation in G6PD-deficient patients. Successful approaches in these vulnerable patients may affect favorably all patients exposed to CPB, ischemia, and reperfusion.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Dogra, G. Puri, and S. Rana Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery Perfusion, November 1, 2010; 25(6): 417 - 421. [Abstract] [PDF] |
||||
![]() |
A. Anthi, R. F. Machado, M. L. Jison, A. M. Taveira-DaSilva, L. J. Rubin, L. Hunter, C. J. Hunter, W. Coles, J. Nichols, N. A. Avila, et al. Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1272 - 1279. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |